The company currently has issued U.S. and European patents and has filed additional patent applications in the U.S. and various foreign jurisdictions. These applications cover a number of innovations with respect to existing clinical practice.
The company’s proprietary know-how is incorporated in analytical reporting, accessed through a web-based portal. Access information is provided only to licensed users.
Further information for prospective partners and investors is available from the company under a confidentiality agreement.